Objective: To observe the effect of Yugan Granule (YGG) in treating patients of chronic hepatitis B infected with basic core promoter (BCP) mutant HBV.

Methods: BCP mutation was detected by microwell liquid hybridization combined with enzyme linked immunosorbent assay (ELISA) and 46 patients were confirmed to be the mutant positive (Group A), and 69 the mutant negative (Group B). All patients were treated by YGG and the clinical symptoms and laboratory parameters before and after treatment were observed.

Results: The scores of symptoms and serum levels of alanine transaminase (ALT) and total bilirubin (TBil) were decreased markedly in both groups after treatment. The HBeAg negative conversion rate in Group A was 60%, obviously higher than that in Group B (30%, P < 0.05), while HBV-DNA negative conversion rate between the two groups had the insignificant difference. The overall efficacy was similar in the two groups.

Conclusion: YGG could remarkably alleviate the symptoms, reduce serum levels of ALT and TBil, and showed the effect of anti-HBV with the same efficacy both to BCP mutant and wild strain HBV infected patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

yugan granule
8
treating patients
8
patients chronic
8
chronic hepatitis
8
basic core
8
core promoter
8
bcp mutant
8
serum levels
8
negative conversion
8
conversion rate
8

Similar Publications

To investigate the therapeutic effects of Biejia Yugan Granule on hepatic fibrosis caused by compound factors in rats and its effect on TGF-β1/Smads signaling pathway. SD rats were randomly divided into blank control group, model control group, colchicine group, Biejia Yugan Granule low, medium and high dose (1.85, 3.

View Article and Find Full Text PDF

To investigate the prevention and treatment effect of (BYG) on ethanol-induced hepatic fibrosis (EHF) rats. SD rats were randomly divided into blank control group, model group, BYG group, colchicine group and BYG low and BYG high dose groups (=8). The EHF rat model was established by intragastric edible ethanol with a gradually increased dose.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists studied how a natural remedy called QYG affects liver diseases in rats suffering from scarring (fibrosis).
  • They divided the rats into different groups and treated them with QYG or other substances after making them sick with chemicals.
  • Results showed that QYG helped improve liver health by balancing certain proteins that protect the liver, making it a good option for treatment.
View Article and Find Full Text PDF

Objective: To observe the effect of Yugan Granule (YGG) in treating patients of chronic hepatitis B infected with basic core promoter (BCP) mutant HBV.

Methods: BCP mutation was detected by microwell liquid hybridization combined with enzyme linked immunosorbent assay (ELISA) and 46 patients were confirmed to be the mutant positive (Group A), and 69 the mutant negative (Group B). All patients were treated by YGG and the clinical symptoms and laboratory parameters before and after treatment were observed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!